Stocks - Europe Seen Lower Ahead of ECB Meeting

Stocks - Europe Seen Lower Ahead of ECB Meeting  | Jul 16, 2020 07:05

Stocks - Europe Seen Lower Ahead of ECB Meeting

By Peter Nurse - European stock markets are seen opening lower Thursday, amid caution over the pace of the global economic recovery ahead of the latest meeting from the European Central Bank.

At 2:05 AM ET (0605 GMT), the DAX futures contract in Germany traded 0.5% lower, the FTSE 100 futures contract in the U.K. fell 0.4%, while CAC 40 futures in France dropped 0.4%.

China reported 3.2% growth in its second quarter GDP year-on-year earlier Thursday, as the world’s second-largest economy returned to growth after the first quarter’s contraction of 6.8%.

But the recovery is still uneven. Separate data showed China's industrial output beat expectations in June, but retail sales unexpectedly fell again, suggesting consumer demand remains weak.

“Although the quarter-on-quarter growth of 11.5% supports the V-shaped recovery narrative, which financial markets have been trading on, year-on-year growth of 3.2% is still the lowest since records began in 1992,” said analyst Amy Yuan Zhuang at Nordea, in a research note. “It suggests that economic activity remains far below the pre-pandemic levels.”

At the same time, the Covid-19 virus continues to work its way through the global population, with the summer tourism season in Europe generating pockets of high-risk gatherings. Tensions between the U.S. and China are also still simmering.

“Lingering uncertainty could prolong the recovery and make the asset price rebound fragile to a correction,” the analyst at Nordea added.

Attention will now turn to the latest ECB get together,  although the central bank is unlikely to deliver another easing package so soon after June’s largesse.

“We think the ECB will strike a more positive note on current economic developments, while continuing to express caution about the outlook further out,” said analysts at ABN Amro, in a research note.

In corporate news, Novartis (SIX:NOVN)will be in focus after the Swiss pharma giant said it will offer medicines on a zero-profit basis to financially-strained countries to help treating Covid-19 patients. 

Oil prices weakened Thursday after the world’s major producers agreed to relax their record cuts to output, but losses have been mitigated by a sizable drop in last week’s official U.S. crude inventories.

The Organization of the Petroleum Exporting Countries and its allies, known as OPEC+, agreed on Wednesday to scale back oil production cuts from August to 7.7 million barrels a day until December, from the 9.7 million barrels per day seen since May. The Energy Information Administration, meanwhile, reported U.S. crude inventories fell 7.5 million barrels last week, much morethan expected.

At 2:05 AM ET, U.S. crude futures traded 0.8% lower at $40.86 a barrel, while the international benchmark Brent contract fell 0.7% to $43.40.

Elsewhere, gold futures fell 0.2% to $1,810.65/oz, while EUR/USD traded at 1.1406, down 0.1%.


Related News

Latest comments

Add a Comment
Please wait a minute before you try to comment again.
Write a reply...
Please wait a minute before you try to comment again.

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

English (USA) English (India) English (Canada) English (Australia) English (South Africa) English (Philippines) English (Nigeria) Deutsch Español (España) Español (México) Français Italiano Nederlands Português (Portugal) Polski Português (Brasil) Русский Türkçe ‏العربية‏ Ελληνικά Svenska Suomi עברית 日本語 한국어 简体中文 繁體中文 Bahasa Indonesia Bahasa Melayu ไทย Tiếng Việt हिंदी
Sign out
Are you sure you want to sign out?
Saving Changes


Download the App

Get free real time quotes, charts and alerts on stocks, indices, currencies, commodities and bonds. Get free top of the line technical analysis/predictors. is better on the App!

More content, faster quotes and charts, and a smoother experience is available only on the App.